LEXINGTON, Mass.--(BUSINESS WIRE)--Jan. 31, 2006--Critical Therapeutics, Inc. (NASDAQ: CRTX), a biopharmaceutical company engaged in the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases, will conduct a conference call at 5:00 p.m. ET Thursday, February 9, following the after-market release of its fourth-quarter and year-end 2005 financial results. Critical Therapeutics President and Chief Executive Officer Paul Rubin, M.D. will lead the call, during which senior management will discuss the Company’s fourth-quarter financial results, additional corporate activities and upcoming milestones.
